 |
|
|
| |
HCV SPRINT-1: Final Results SVR 24 NS3 Protease Inhibitor Boceprevir plus PegIFN alpha-2b/Ribavirin HCV 1 Treatment Naïve Patients
|
| |
| |
EASL
April 23, 2009
Copenhagen, Denmark
Reported by Jules Levin
Paul Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff,
John M Vierling, David Pound, Mitchell Davis, Joseph S Galati,
Stuart C Gordon, Natarajan Ravendhran, Lorenzo Rossaro,
Frank H Anderson, Ira M Jacobson, Raymond Rubin,
Kenneth Koury, Lisa Pedicone, Eirum Chaudhri, and Janice K Albrecht
|
| |
|
|
|
|
|
